Information:
Error:
ID
30796
Description
Study part: SF- 36 Health Survey Day 0. A Phase III, Multicenter, Randomized, Double-Masked, Sham Injection-Controlled Study Of The Efficacy And Safety Of rhuFab V2 (Ranibizumab) In Subjects With Minimally Classic Or Occult Subfoveal Neovascular Age-Related Macular Degeneration.
Keywords
Versions (3)
- 2/18/18 2/18/18 -
- 6/20/18 6/20/18 - Julian Varghese
- 6/20/18 6/20/18 - Julian Varghese
Copyright Holder
Roche
Uploaded on
June 20, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
SF- 36 Health Survey Day 0 rhuFab V2 Neovascular Age-Related Macular Degeneration FVF2598g
SF- 36 Health Survey Day 0
- StudyEvent: ODM
Similar models
SF- 36 Health Survey Day 0
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Subject Number
Item
Subject Number:
text
C2348585 (UMLS CUI [1])
Subject Initials
Item
Subject Initials:
text
C1997894 (UMLS CUI [1,1])
C2986440 (UMLS CUI [1,2])
C2986440 (UMLS CUI [1,2])
Visit Date
Item
Visit Date:
date
C1320303 (UMLS CUI [1])
Date
Item
Date Administered:
date
C0011008 (UMLS CUI [1])
Score SF- 36 Health Survey
Item
SF- 36 Health Survey Score
text
C0449820 (UMLS CUI [1,1])
C0451287 (UMLS CUI [1,2])
C0451287 (UMLS CUI [1,2])